ONCOLOGY

Cancer and cancer treatments damage to cells, compromising immune function and reducing cellular integrity. By tracking phase angle, oncologists can monitor patients' cellular health for to detect symptoms and disease progressionm earlier.

Phase angle, a measure of how the cells respond to the electrical currents used to measure body composition, reflects cell membrane integrity and has been linked to survival in various oncological populations. When cells are healthy, they can better resist these currents utilized by the InBody, resulting in a higher phase angle. Because cancer and various treatment modalities cause damage to the cells before the loss of muscle and fat mass, this decrease in phase angle can be linked to cancer-cachexia-related malnutrition as well as other medical risks/conditions. By monitoring segmental and phase angles, oncologists can pinpoint the risk of specific comorbidities, track the effects of immunotherapies more precisely, and provide earlier intervention strategies to prevent of disease progression.

For clients looking to build muscle mass, a proper dietary program is required to optimize results and ensure weight gain occurs in the form of muscle mass. Understanding a starting point and the desired outcome for the client helps establish a better end goal, a realistic timeline for tracking progress, and a direction for where changes in body composition need to occur. Using BIA technology, the Muscle-Fat Analysis section offers nutritionists and dietitians a better way to monitor the progress of their ’clients' programs and allow for earlier dietary interventions to optimize their success.

While research supports the use of protein in addition to resistance training to increase skeletal muscle mass, a proper macronutrient balance is required to avoid plateaus and ensure that weight gain occurs in the form of muscle mass and not fat mass. By analyzing the change in the balance between muscle and fat mass, clients can be assured that the changes being made to their composition are of a positive nature. Clients can monitor ,their dietary regime's or supplements' effectiveness, which ultimately provides credibility to the nutritionist’s recommendation and programming.

For clients looking to build muscle mass, a proper dietary program is required to optimize results and ensure weight gain occurs in the form of muscle mass. Understanding a starting point as well as the desired outcome for the client helps establish a better end goal, a realistic timeline for tracking progress and direction for where changes in body composition need to occur. Through the use of BIA technology the Muscle-Fat Analysis section offers nutritionists and dietitians a better way to monitor the progress of their client’s program and allow for earlier dietary interventions to optimize their success.

While research supports the use of protein in addition to resistance training to increase skeletal muscle mass, a proper macronutrient balance is required in order to avoid plateaus and ensure that weight gain occurs in the form of muscle mass and not fat mass. By analyzing the change in the balance between muscle and fat mass, clients can be assured that the changes being made to their composition is that of a positive nature. Clients can monitor the effectiveness of their dietary regime or supplements, which ultimately provides credibility to the nutritionist’s recommendation and programming.

Cancer leads to muscle loss compromises organs and cellular functions,and can lead to systemic inflammation or edema. InBody’s technology can precisely track fluid changes across the body to understand the cause of imbalanced fluid levels.

InBody effectively distinguishes water in the intracellular (ICW; within the tissues) and extracellular (ECW; within the blood and interstitial fluids) compartments that make up total body water (TBW). The Edema Index, based on the ratio between ECW and TBW (ECW/TBW),distinguish fluid imbalances resulting from malnutrition or edema. Managing increases in Edema Index is a priority for improving patient outcomes.

Due to the high water content of muscles, loss of muscle mass causes a reduction in ICW and results in an increased Edema Index. Thus, the Edema Index can be identify malnutrition separately from other disease-related fluid imbalances.

Since cancer symptoms are associated with increased systemic inflammation, progressing fluid imbalances are linked to poor patient outcomes. The Edema Index can be used to identify and monitor long-term fluid retention, which causes cellular stress and may lead to comorbidities such as renal or cardiac dysfunction. By tracking whole-body ECW/TBW, the efficacy of anti-inflammatory drugs can be assessed and used to guide clinical decisions. Additionally, segmental Edema Index scores are essential for identifying localized fluid imbalances in the limbs or trunk, aiding in the earlier detection of cancer-related lymphedema or circulation issues.